CEACAM5 and colorectal carcinoma: Carcinoembryonic antigen (CEA) is regarded as an essential indicator of CRC prognosis (4), and the guidelines recommend that serum CEA should be measured preoperatively and postoperatively in patients with CRC (5–9).